These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 193633

  • 1. Immunoelectron microscopic studies of antibodies in mouse sera directed against mouse mammary tumor virus.
    Miller MF, Dmochowski L, Bowen JM.
    Cancer Res; 1977 Jul; 37(7 Pt 1):2086-91. PubMed ID: 193633
    [Abstract] [Full Text] [Related]

  • 2. Implications of humoral antibody in mice and humans to breast tumor and mouse mammary tumor virus-associated antigens.
    Bowen JM, Dmochowski L, Miller MF, Priori ES, Seman G, Dodson ML, Maruyama K.
    Cancer Res; 1976 Feb; 36(2 pt 2):759-64. PubMed ID: 175935
    [Abstract] [Full Text] [Related]

  • 3. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
    Ihle JN, Arthur LO, Fine DL.
    Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
    [Abstract] [Full Text] [Related]

  • 4. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM, Smith BA, Stolfi RL, Martin DS.
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [Abstract] [Full Text] [Related]

  • 5. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
    Schochetman G, Arthur LO, Long CW, Massey RJ.
    J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
    [Abstract] [Full Text] [Related]

  • 6. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors.
    Michalides R, Wagenaar E, Nusse R.
    J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283
    [Abstract] [Full Text] [Related]

  • 7. Humoral and cellular immune responses to mouse mammary tumor virus (MMTV) in experimental animal models (review).
    Lopez DM.
    Anticancer Res; 1984 Apr; 4(4-5):305-12. PubMed ID: 6091529
    [Abstract] [Full Text] [Related]

  • 8. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains.
    Girardi AJ, Dion AS, Holben JA.
    J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052
    [Abstract] [Full Text] [Related]

  • 9. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV, Dudley JP, Ross SR.
    J Immunol; 1998 Sep 01; 161(5):2375-82. PubMed ID: 9725233
    [Abstract] [Full Text] [Related]

  • 10. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma.
    Holder WD, Wells SA.
    Cancer Res; 1983 Jan 01; 43(1):239-44. PubMed ID: 6291754
    [Abstract] [Full Text] [Related]

  • 11. Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus.
    Squartini F, Basolo F, Bistocchi M.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):5879-82. PubMed ID: 6315219
    [Abstract] [Full Text] [Related]

  • 12. Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions.
    Slagle BL, Medina D, Butel JS.
    J Natl Cancer Inst; 1987 Aug 01; 79(2):323-35. PubMed ID: 3037152
    [Abstract] [Full Text] [Related]

  • 13. Mammary tumorigenesis and tumor morphology in four C3H sublines with or without exogenous mammary tumor virus.
    Vaage J, Smith GH, Asch BB, Teramoto Y.
    Cancer Res; 1986 Apr 01; 46(4 Pt 2):2096-100. PubMed ID: 2418961
    [Abstract] [Full Text] [Related]

  • 14. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice.
    Girardi AJ, Dion AS, Pomenti AA, Holben JA.
    J Natl Cancer Inst; 1985 Feb 01; 74(2):405-13. PubMed ID: 2983136
    [Abstract] [Full Text] [Related]

  • 15. C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus.
    Massey R, Arthur LO, Long CW, Schochetman G.
    J Virol; 1980 Jan 01; 33(1):123-8. PubMed ID: 6154146
    [Abstract] [Full Text] [Related]

  • 16. Immunological reaction between sera from neutron-irradiated W/FU rats and mouse mammary tumor virus.
    Imai M, Sumi C, Nagayoshi S, Hoshino M, Yokoro K.
    Gan; 1981 Feb 01; 72(1):132-40. PubMed ID: 6268478
    [Abstract] [Full Text] [Related]

  • 17. Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression.
    Wei WZ, Gill RF, Wang H.
    Semin Cancer Biol; 1993 Jun 01; 4(3):205-13. PubMed ID: 8391342
    [Abstract] [Full Text] [Related]

  • 18. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
    Slagle BL, Lanford RE, Medina D, Butel JS.
    Cancer Res; 1984 May 01; 44(5):2155-62. PubMed ID: 6324998
    [Abstract] [Full Text] [Related]

  • 19. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun 01; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 20. Ubiquity of natural antibodies to the mammary tumour virus in mice.
    Bentvelzen P, Brinkhof J.
    Arch Geschwulstforsch; 1980 Jun 01; 50(3):193-203. PubMed ID: 6254462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.